Crossmark

Respiratory Virus Vaccines: Pathways to Recommendations and Enhanced Coverage for At-Risk Populations

Published Online: 2024-12-30

Published Print: 2025-01

Authors

Maggi, Stefania https://orcid.org/0000-0002-0453-8663
Launay, Odile

Dawson, Rachel
License Information

Text and Data Mining valid from 2024-12-30

Version of Record valid from 2024-12-30
More Information

Article History

Received: 3 June 2024

Accepted: 6 November 2024

First Online: 30 December 2024

Declarations

:

: Stefania Maggi has speaking engagements/honoraria/research grants from: Moderna, Merck, Pfizer, Sanofi, GSK, Janssen, and BioNTech. Rachel Dawson is an employee of Moderna, Inc., and holds stock/stock options in the company. Odile Launay has speaking engagements/honoraria/research grants from: Moderna, Merck, Pfizer, Sanofi, GSK, and Janssen.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.

Document is current